首页 > 最新文献

Supportive Care in Cancer最新文献

英文 中文
Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia. 急性淋巴细胞白血病儿童治疗相关肝毒性的脂质组学特征
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-17 DOI: 10.1007/s00520-026-10414-6
Emily J Mason, Jeremy M Schraw, John P Woodhouse, M Monica Gramatges, Kevin J Williams, Baojiang Chen, Melissa B Harrell, Olga A Taylor, Michael E Scheurer, Philip J Lupo, Karen R Rabin, Joanna S Yi, Van Huynh, Steven D Mittelman, Etan Orgel, Austin Brown

Introduction: Treatment for childhood acute lymphoblastic leukemia (ALL) can result in hepatotoxicity. Despite being a common complication of ALL therapy, mechanisms and biomarkers of treatment-associated hepatotoxicity (TAH) are not well described.

Methods: We conducted lipidomic profiling to identify plasma lipids associated with TAH in children receiving ALL therapy utilizing a nested case-control framework. TAH was defined as (1) transaminitis: ALT/AST ≥ CTCAE grade 3, and/or (2) conjugated hyperbilirubinemia: > 3.0 mg/dL during induction therapy or > 2.0 mg/dL post induction. A total of 90 patients (45 matched pairs) treated at Texas Children's Hospital between 2012 and 2021 were selected for lipidomic profiling, with controls matched to cases based on the availability of samples collected at similar time points in therapy. Lipidomic profiling quantified 1056 lipids, with 751 retained after quality control. Associations with TAH were evaluated using multivariable conditional logistic regression controlling for age, diagnostic BMI z-score, race/ethnicity, and induction intensity.

Results: The cohort was 55% male, 50% Hispanic, with a mean diagnostic age of 5 years. We identified 110 lipids nominally associated with TAH post-sample collection (p < 0.05). Lipid classes phosphatidylcholines (PCs; Holm-p = 5 × 10-6) and sphingomyelins (SMs; Holm-p = 0.0009) were significantly enriched in cases.

Discussion: We identified plasma lipid profiles, characterized by elevated PCs and SMs with reduced triglycerides, associated with the incidence of TAH in children with ALL. Similar patterns have been linked to metabolic liver disease in adults and children. These findings suggest lipid dysregulation may contribute to TAH susceptibility and highlight candidate biomarkers for future validation in larger cohorts.

儿童急性淋巴细胞白血病(ALL)的治疗可导致肝毒性。尽管是ALL治疗的常见并发症,但治疗相关肝毒性(TAH)的机制和生物标志物尚未得到很好的描述。方法:我们采用嵌套病例对照框架,对接受ALL治疗的儿童进行脂质组学分析,以确定与TAH相关的血浆脂质。TAH定义为(1)转氨炎:ALT/AST≥CTCAE 3级,和/或(2)结合性高胆红素血症:诱导治疗期间> 3.0 mg/dL或诱导后> 2.0 mg/dL。在2012年至2021年期间,在德克萨斯儿童医院接受治疗的总共90名患者(45对配对)被选择进行脂质组学分析,对照组根据治疗中相似时间点收集的样本的可用性与病例相匹配。脂质组学分析定量了1056种脂质,质量控制后保留751种。使用控制年龄、诊断性BMI z-score、种族/民族和诱导强度的多变量条件逻辑回归来评估与TAH的关联。结果:该队列55%为男性,50%为西班牙裔,平均诊断年龄为5岁。我们鉴定了110种名义上与TAH相关的脂质(p -6)和鞘磷脂(SMs; Holm-p = 0.0009)在病例中显著富集。讨论:我们确定了血浆脂质谱,其特征是pc和SMs升高,甘油三酯降低,与ALL患儿的TAH发生率相关。类似的模式与成人和儿童的代谢性肝病有关。这些发现表明,脂质失调可能导致TAH易感性,并突出了候选生物标志物,以供将来在更大的队列中验证。
{"title":"Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia.","authors":"Emily J Mason, Jeremy M Schraw, John P Woodhouse, M Monica Gramatges, Kevin J Williams, Baojiang Chen, Melissa B Harrell, Olga A Taylor, Michael E Scheurer, Philip J Lupo, Karen R Rabin, Joanna S Yi, Van Huynh, Steven D Mittelman, Etan Orgel, Austin Brown","doi":"10.1007/s00520-026-10414-6","DOIUrl":"https://doi.org/10.1007/s00520-026-10414-6","url":null,"abstract":"<p><strong>Introduction: </strong>Treatment for childhood acute lymphoblastic leukemia (ALL) can result in hepatotoxicity. Despite being a common complication of ALL therapy, mechanisms and biomarkers of treatment-associated hepatotoxicity (TAH) are not well described.</p><p><strong>Methods: </strong>We conducted lipidomic profiling to identify plasma lipids associated with TAH in children receiving ALL therapy utilizing a nested case-control framework. TAH was defined as (1) transaminitis: ALT/AST ≥ CTCAE grade 3, and/or (2) conjugated hyperbilirubinemia: > 3.0 mg/dL during induction therapy or > 2.0 mg/dL post induction. A total of 90 patients (45 matched pairs) treated at Texas Children's Hospital between 2012 and 2021 were selected for lipidomic profiling, with controls matched to cases based on the availability of samples collected at similar time points in therapy. Lipidomic profiling quantified 1056 lipids, with 751 retained after quality control. Associations with TAH were evaluated using multivariable conditional logistic regression controlling for age, diagnostic BMI z-score, race/ethnicity, and induction intensity.</p><p><strong>Results: </strong>The cohort was 55% male, 50% Hispanic, with a mean diagnostic age of 5 years. We identified 110 lipids nominally associated with TAH post-sample collection (p < 0.05). Lipid classes phosphatidylcholines (PCs; Holm-p = 5 × 10<sup>-6</sup>) and sphingomyelins (SMs; Holm-p = 0.0009) were significantly enriched in cases.</p><p><strong>Discussion: </strong>We identified plasma lipid profiles, characterized by elevated PCs and SMs with reduced triglycerides, associated with the incidence of TAH in children with ALL. Similar patterns have been linked to metabolic liver disease in adults and children. These findings suggest lipid dysregulation may contribute to TAH susceptibility and highlight candidate biomarkers for future validation in larger cohorts.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"209"},"PeriodicalIF":3.0,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146207684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating psychosocial support into multidisciplinary lung cancer care: a roadmap for stages I-III NSCLC. 将社会心理支持纳入多学科肺癌治疗:I-III期非小细胞肺癌的路线图
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-16 DOI: 10.1007/s00520-026-10451-1
Xueling Wang, Xiaodong Niu, Xinyi Tu, Guowei Che, Qinghua Zhou, Lingling Zhu
{"title":"Integrating psychosocial support into multidisciplinary lung cancer care: a roadmap for stages I-III NSCLC.","authors":"Xueling Wang, Xiaodong Niu, Xinyi Tu, Guowei Che, Qinghua Zhou, Lingling Zhu","doi":"10.1007/s00520-026-10451-1","DOIUrl":"https://doi.org/10.1007/s00520-026-10451-1","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"207"},"PeriodicalIF":3.0,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146202488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between swallowing function, activities of daily living, and eating posture in patients with terminal cancer. 晚期癌症患者吞咽功能、日常生活活动和进食姿势的关系
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-16 DOI: 10.1007/s00520-026-10447-x
Takahiro Yamamoto, Takaaki Kubo

Purpose: Patients with terminal cancer often have swallowing dysfunction (dysphagia), which is associated with quality of life. Dysphagia has been reported to be associated with cancer treatment, physical decline, or poor eating posture. However, its relationship with activities of daily living (ADLs) and eating posture has rarely been studied. This study examined these associations in patients with terminal cancer.

Methods: This cross-sectional observational study included patients admitted to a palliative care unit between November 2018 and April 2024 who underwent rehabilitation. Data included age, sex, swallowing function (Functional Oral Intake Scale [FOIS]), ADLs (Functional Independence Measure [FIM]), eating posture (upright sitting, chair sitting, full gatch-up, high-angle, low-angle), and Palliative Prognostic Index (PPI). Patients were categorized into tube-dependent (FOIS 1-3) and oral intake (FOIS 4-7) groups. Group comparisons used the Mann-Whitney U test. Multivariate logistic regression examined associations between swallowing function, ADLs, eating posture, adjusting for age, sex, PPI, and sleepiness.

Results: Among 201 patients (mean age 82.0 ± 10.8 years), 26.4% were tube-dependent. Swallowing function was significantly associated with mFIM (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.01-1.05, P = 0.002), cFIM (OR 1.07, 95% CI 1.02-1.12, P = 0.002), total FIM (OR 1.03, 95% CI 1.01-1.05, P < 0.001), and upright sitting (OR 2.92, 95% CI 1.12-7.62, P = 0.029).

Conclusion: Swallowing function in patients with terminal cancer was associated with ADLs and eating posture. The cross-sectional design limits causal inference, and prospective studies are needed.

目的:晚期癌症患者常出现吞咽功能障碍(吞咽困难),这与生活质量有关。据报道,吞咽困难与癌症治疗、身体衰退或不良饮食姿势有关。然而,它与日常生活活动(ADLs)和饮食姿势的关系却很少被研究。这项研究在晚期癌症患者中检验了这些关联。方法:本横断面观察性研究纳入了2018年11月至2024年4月期间入住姑息治疗病房接受康复治疗的患者。数据包括年龄、性别、吞咽功能(功能性口服摄入量表[FOIS])、ADLs(功能独立性量表[FIM])、进食姿势(直立坐、椅式坐、完全抬高、高角度、低角度)和姑息预后指数(PPI)。患者分为管依赖组(FOIS 1-3)和口服组(FOIS 4-7)。组间比较采用Mann-Whitney U检验。多变量逻辑回归检验了吞咽功能、ADLs、饮食姿势、调整年龄、性别、PPI和嗜睡之间的关系。结果:201例患者(平均年龄82.0±10.8岁)中,26.4%为管依赖。吞咽功能与mFIM(比值比[OR] 1.03, 95%可信区间[CI] 1.01-1.05, P = 0.002)、cFIM(比值比[OR] 1.07, 95% CI 1.02-1.12, P = 0.002)、总FIM(比值比[OR] 1.03, 95% CI 1.01-1.05, P)显著相关。结论:晚期癌症患者吞咽功能与ADLs和饮食姿势相关。横断面设计限制了因果推理,需要前瞻性研究。
{"title":"Association between swallowing function, activities of daily living, and eating posture in patients with terminal cancer.","authors":"Takahiro Yamamoto, Takaaki Kubo","doi":"10.1007/s00520-026-10447-x","DOIUrl":"https://doi.org/10.1007/s00520-026-10447-x","url":null,"abstract":"<p><strong>Purpose: </strong>Patients with terminal cancer often have swallowing dysfunction (dysphagia), which is associated with quality of life. Dysphagia has been reported to be associated with cancer treatment, physical decline, or poor eating posture. However, its relationship with activities of daily living (ADLs) and eating posture has rarely been studied. This study examined these associations in patients with terminal cancer.</p><p><strong>Methods: </strong>This cross-sectional observational study included patients admitted to a palliative care unit between November 2018 and April 2024 who underwent rehabilitation. Data included age, sex, swallowing function (Functional Oral Intake Scale [FOIS]), ADLs (Functional Independence Measure [FIM]), eating posture (upright sitting, chair sitting, full gatch-up, high-angle, low-angle), and Palliative Prognostic Index (PPI). Patients were categorized into tube-dependent (FOIS 1-3) and oral intake (FOIS 4-7) groups. Group comparisons used the Mann-Whitney U test. Multivariate logistic regression examined associations between swallowing function, ADLs, eating posture, adjusting for age, sex, PPI, and sleepiness.</p><p><strong>Results: </strong>Among 201 patients (mean age 82.0 ± 10.8 years), 26.4% were tube-dependent. Swallowing function was significantly associated with mFIM (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.01-1.05, P = 0.002), cFIM (OR 1.07, 95% CI 1.02-1.12, P = 0.002), total FIM (OR 1.03, 95% CI 1.01-1.05, P < 0.001), and upright sitting (OR 2.92, 95% CI 1.12-7.62, P = 0.029).</p><p><strong>Conclusion: </strong>Swallowing function in patients with terminal cancer was associated with ADLs and eating posture. The cross-sectional design limits causal inference, and prospective studies are needed.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"208"},"PeriodicalIF":3.0,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146207474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial. 异基因造血干细胞移植患者补充大剂量维生素C:一项随机、三盲、安慰剂对照试验
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-16 DOI: 10.1007/s00520-026-10434-2
Shima Heidari, Bita Shahrami, Soroush Rad, Kourosh Sadeghi, Leyla Sharifi Aliabadi, Molouk Hadjibabaei, Mohammad Vaezi

Purpose: Allogenic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for hematological disorders but often results in micronutrients deficiency and complications. Vitamin C, a potent antioxidant, may improve endothelial function, tissue protection, and immune recovery. This study evaluated the effects of early high-dose vitamin C supplementation on plasma vitamin C levels and post-HSCT complications.

Methods: In this pilot, triple-blind, placebo-controlled trial, 31 adult allo-HSCT patients were randomized to receive intravenous vitamin C (50 mg/kg/day) or placebo from day + 1 to + 14, followed by oral vitamin C (500 mg/day) or placebo until day + 100. Plasma vitamin C levels were measured at days 0, + 7, + 15, and discharge. Patients were monitored for post-HSCT complications until day + 100.

Results: Plasma vitamin C levels were significantly higher in the vitamin C group at all time points (P < 0.001). Trends toward reduced acute graft-versus-host disease (33% vs. 44%), lower oral mucositis severity (46.6% vs. 62.5%), and shorter duration (7.5 ± 3.6 vs. 9.1 ± 3.7 days) were observed, though not statistically significant. No significant adverse events were reported.

Conclusion: High-dose vitamin C effectively corrected plasma levels, and while trends toward reduced complications were observed in allo-HSCT patients, larger trials are needed to confirm these findings.

目的:同种异体造血干细胞移植(Allogenic hematopoietic stem cell transplantation, alloo - hsct)是治疗血液系统疾病的一种有效方法,但经常导致微量营养素缺乏和并发症。维生素C是一种有效的抗氧化剂,可以改善内皮功能、组织保护和免疫恢复。本研究评估了早期高剂量维生素C补充对血浆维生素C水平和造血干细胞移植后并发症的影响。方法:在这项试点、三盲、安慰剂对照试验中,31名成人同种异体造血干细胞移植患者从第1天到第14天随机接受静脉注射维生素C (50 mg/kg/天)或安慰剂,然后口服维生素C (500 mg/天)或安慰剂,直到第100天。在第0天、第7天、第15天和出院时测定血浆维生素C水平。对患者进行hsct后并发症监测,直至第100天。结论:高剂量维生素C可有效纠正血浆维生素C水平,尽管在同种异体造血干细胞移植患者中观察到并发症减少的趋势,但需要更大规模的试验来证实这些发现。
{"title":"High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial.","authors":"Shima Heidari, Bita Shahrami, Soroush Rad, Kourosh Sadeghi, Leyla Sharifi Aliabadi, Molouk Hadjibabaei, Mohammad Vaezi","doi":"10.1007/s00520-026-10434-2","DOIUrl":"https://doi.org/10.1007/s00520-026-10434-2","url":null,"abstract":"<p><strong>Purpose: </strong>Allogenic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for hematological disorders but often results in micronutrients deficiency and complications. Vitamin C, a potent antioxidant, may improve endothelial function, tissue protection, and immune recovery. This study evaluated the effects of early high-dose vitamin C supplementation on plasma vitamin C levels and post-HSCT complications.</p><p><strong>Methods: </strong>In this pilot, triple-blind, placebo-controlled trial, 31 adult allo-HSCT patients were randomized to receive intravenous vitamin C (50 mg/kg/day) or placebo from day + 1 to + 14, followed by oral vitamin C (500 mg/day) or placebo until day + 100. Plasma vitamin C levels were measured at days 0, + 7, + 15, and discharge. Patients were monitored for post-HSCT complications until day + 100.</p><p><strong>Results: </strong>Plasma vitamin C levels were significantly higher in the vitamin C group at all time points (P < 0.001). Trends toward reduced acute graft-versus-host disease (33% vs. 44%), lower oral mucositis severity (46.6% vs. 62.5%), and shorter duration (7.5 ± 3.6 vs. 9.1 ± 3.7 days) were observed, though not statistically significant. No significant adverse events were reported.</p><p><strong>Conclusion: </strong>High-dose vitamin C effectively corrected plasma levels, and while trends toward reduced complications were observed in allo-HSCT patients, larger trials are needed to confirm these findings.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"206"},"PeriodicalIF":3.0,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146202467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of social determinants on care for veterans with cancer: a qualitative study. 社会决定因素对退伍军人癌症护理的影响:一项定性研究。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-14 DOI: 10.1007/s00520-026-10444-0
Sam Z Thalji, M Muska Nataliansyah, Meghan Conroy, Susan Tsai Mhs, Philip N Redlich, David A Nelson

Purpose: The Veterans Health Administration created initiatives to enhance the monitoring of Social Determinants of Health (SDOH) among Veterans in the primary care setting. There remains suboptimal communication between primary care and cancer care specialties.

Methods: In-depth interviews were conducted at a VA medical center among primary care physicians, social workers, and cancer care physicians. Participants described how SDOH affect Veterans with cancer and identified strengths and weaknesses in the current communication channels between specialties. Interviews were audio-recorded, transcribed, and coded. Key themes were identified using inductive analysis based on the grounded theory.

Results: There were four major themes: (1) social issues disrupt treatment and lead to worse outcomes; (2) social challenges drive Veterans' attention and resources away from their treatment; (3) navigating current systems requires institutional experience to overcome barriers; (4) all members of the care team have a role in addressing SDOH. The most common SDOH affecting this population include housing instability, transportation, food insecurity, and social support. SDOH and communication between care settings were considered primary barriers to care for Veterans with cancer.

Conclusion: The opportunity to improve the social support and care for Veterans with cancer would be enhanced by a structured and purposeful discussion to include social issues before treatment begins. The findings helped to inform the development of two interventions: creating an accessible template in the electronic medical record to summarize SDOH needs and the inclusion of primary care physicians and social workers at the initial tumor board discussion for Veterans with a new diagnosis of cancer.

目的:退伍军人健康管理局制定了倡议,以加强对初级保健机构退伍军人健康的社会决定因素(SDOH)的监测。初级保健和癌症护理专业之间的沟通仍然不够理想。方法:在VA医疗中心对初级保健医生、社会工作者和癌症护理医生进行深度访谈。与会者描述了SDOH如何影响患有癌症的退伍军人,并确定了目前各专业之间沟通渠道的优势和劣势。采访被录音、转录和编码。在扎根理论的基础上,利用归纳分析确定了关键主题。结果:有四大主题:(1)社会问题干扰治疗,导致治疗效果恶化;(2)社会挑战导致退伍军人的注意力和资源远离他们的治疗;(3)在现行制度中导航需要制度性经验来克服障碍;(4)护理团队的所有成员都有解决SDOH的作用。影响这一人口的最常见的SDOH包括住房不稳定、交通、粮食不安全和社会支持。SDOH和护理机构之间的沟通被认为是护理癌症退伍军人的主要障碍。结论:在治疗开始前,通过结构化和有目的的讨论,包括社会问题,将有机会改善对患有癌症的退伍军人的社会支持和照顾。这些发现有助于为两种干预措施的发展提供信息:在电子病历中创建一个可访问的模板,以总结SDOH的需求,并在新诊断为癌症的退伍军人的最初肿瘤委员会讨论中纳入初级保健医生和社会工作者。
{"title":"The impact of social determinants on care for veterans with cancer: a qualitative study.","authors":"Sam Z Thalji, M Muska Nataliansyah, Meghan Conroy, Susan Tsai Mhs, Philip N Redlich, David A Nelson","doi":"10.1007/s00520-026-10444-0","DOIUrl":"https://doi.org/10.1007/s00520-026-10444-0","url":null,"abstract":"<p><strong>Purpose: </strong>The Veterans Health Administration created initiatives to enhance the monitoring of Social Determinants of Health (SDOH) among Veterans in the primary care setting. There remains suboptimal communication between primary care and cancer care specialties.</p><p><strong>Methods: </strong>In-depth interviews were conducted at a VA medical center among primary care physicians, social workers, and cancer care physicians. Participants described how SDOH affect Veterans with cancer and identified strengths and weaknesses in the current communication channels between specialties. Interviews were audio-recorded, transcribed, and coded. Key themes were identified using inductive analysis based on the grounded theory.</p><p><strong>Results: </strong>There were four major themes: (1) social issues disrupt treatment and lead to worse outcomes; (2) social challenges drive Veterans' attention and resources away from their treatment; (3) navigating current systems requires institutional experience to overcome barriers; (4) all members of the care team have a role in addressing SDOH. The most common SDOH affecting this population include housing instability, transportation, food insecurity, and social support. SDOH and communication between care settings were considered primary barriers to care for Veterans with cancer.</p><p><strong>Conclusion: </strong>The opportunity to improve the social support and care for Veterans with cancer would be enhanced by a structured and purposeful discussion to include social issues before treatment begins. The findings helped to inform the development of two interventions: creating an accessible template in the electronic medical record to summarize SDOH needs and the inclusion of primary care physicians and social workers at the initial tumor board discussion for Veterans with a new diagnosis of cancer.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"204"},"PeriodicalIF":3.0,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer navigation in Africa: challenges, impacts, and future directions. 非洲癌症导航:挑战、影响和未来方向。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-14 DOI: 10.1007/s00520-026-10426-2
Abiodun Adegbesan, Adewunmi Akingbola, Samuel Tundealao, Boluwatife Olu Afolabi, Stephen Oluwatimilehin Adekoya, Miracle Ifeoluwa Abraham, Onyinye Udeobi, Olajuwon Omotolani Oduntan, Akosile Abiodun Oyeyemi, Uchechukwu Shagaya, Joel Chuku

Cancer navigation guides patients through cancer care, addressing barriers like late diagnosis, financial constraints, and emotional distress. In Africa, it supports early detection, treatment, and survivorship amid poor infrastructure and limited access. Expanding these programs can reduce mortality and improve outcomes. Cancer cases are rising rapidly in Africa and are expected to double by 2050. Access to care is hindered by limited facilities, few trained oncologists, geographic barriers, cultural stigma, high treatment costs, and lack of screening programs. Most services are urban-centered, leaving rural areas underserved. Financial hardship, poor governance, inadequate research funding, and scarce cancer registries worsen the problem. Coordinated, sustainable efforts are needed to improve cancer prevention, treatment, and care. Patient navigation significantly enhances cancer care in sub-Saharan Africa by addressing barriers to early detection, diagnosis, treatment, and support. Navigators facilitate screening, improve awareness, and coordinate care across healthcare levels. They reduce treatment delays, offer psychosocial support to patients and caregivers, and help with financial, transport, and lodging challenges. Successful programs in South Africa, Uganda, and Nigeria demonstrate improved outcomes, including increased screenings, faster diagnoses, and better treatment adherence, showcasing the transformative impact of navigation on cancer control in resource-limited settings. Strengthening cancer navigation systems is essential, focusing on healthcare infrastructure, workforce training, policy reform, and community engagement. Key strategies include expanding cancer centers, integrating trained patient navigators (both clinical and non-clinical navigators), leveraging telemedicine and AI, and increasing collaborations. Formal navigator certification, education campaigns, and improved health financing are crucial. These efforts aim to improve cancer detection, treatment, and outcomes across Africa's diverse healthcare settings.

癌症导航引导患者完成癌症治疗,解决诸如晚期诊断、经济限制和情绪困扰等障碍。在非洲,在基础设施薄弱和获取途径有限的情况下,它支持早期发现、治疗和存活。扩大这些项目可以降低死亡率并改善结果。非洲的癌症病例正在迅速上升,预计到2050年将翻一番。设施有限、训练有素的肿瘤学家很少、地理障碍、文化耻辱、高昂的治疗费用和缺乏筛查项目阻碍了患者获得医疗服务。大多数服务都以城市为中心,农村地区服务不足。财政困难、治理不善、研究经费不足以及癌症登记不足使问题更加恶化。需要协调、可持续的努力来改善癌症的预防、治疗和护理。患者导航通过解决早期发现、诊断、治疗和支持方面的障碍,显著提高了撒哈拉以南非洲地区的癌症护理水平。导航器有助于筛选、提高认识并协调医疗保健级别之间的护理。他们减少了治疗延误,为患者和护理人员提供社会心理支持,并帮助解决经济、交通和住宿方面的挑战。在南非、乌干达和尼日利亚成功实施的项目取得了成效,包括增加筛查、加快诊断和提高治疗依从性,展示了导航技术在资源有限的环境中对癌症控制的变革性影响。加强癌症导航系统至关重要,重点是卫生保健基础设施、劳动力培训、政策改革和社区参与。关键战略包括扩大癌症中心,整合训练有素的患者导航员(包括临床和非临床导航员),利用远程医疗和人工智能,以及加强合作。正式领航员认证、教育运动和改善卫生筹资至关重要。这些努力旨在改善非洲不同医疗保健环境中的癌症检测、治疗和结果。
{"title":"Cancer navigation in Africa: challenges, impacts, and future directions.","authors":"Abiodun Adegbesan, Adewunmi Akingbola, Samuel Tundealao, Boluwatife Olu Afolabi, Stephen Oluwatimilehin Adekoya, Miracle Ifeoluwa Abraham, Onyinye Udeobi, Olajuwon Omotolani Oduntan, Akosile Abiodun Oyeyemi, Uchechukwu Shagaya, Joel Chuku","doi":"10.1007/s00520-026-10426-2","DOIUrl":"https://doi.org/10.1007/s00520-026-10426-2","url":null,"abstract":"<p><p>Cancer navigation guides patients through cancer care, addressing barriers like late diagnosis, financial constraints, and emotional distress. In Africa, it supports early detection, treatment, and survivorship amid poor infrastructure and limited access. Expanding these programs can reduce mortality and improve outcomes. Cancer cases are rising rapidly in Africa and are expected to double by 2050. Access to care is hindered by limited facilities, few trained oncologists, geographic barriers, cultural stigma, high treatment costs, and lack of screening programs. Most services are urban-centered, leaving rural areas underserved. Financial hardship, poor governance, inadequate research funding, and scarce cancer registries worsen the problem. Coordinated, sustainable efforts are needed to improve cancer prevention, treatment, and care. Patient navigation significantly enhances cancer care in sub-Saharan Africa by addressing barriers to early detection, diagnosis, treatment, and support. Navigators facilitate screening, improve awareness, and coordinate care across healthcare levels. They reduce treatment delays, offer psychosocial support to patients and caregivers, and help with financial, transport, and lodging challenges. Successful programs in South Africa, Uganda, and Nigeria demonstrate improved outcomes, including increased screenings, faster diagnoses, and better treatment adherence, showcasing the transformative impact of navigation on cancer control in resource-limited settings. Strengthening cancer navigation systems is essential, focusing on healthcare infrastructure, workforce training, policy reform, and community engagement. Key strategies include expanding cancer centers, integrating trained patient navigators (both clinical and non-clinical navigators), leveraging telemedicine and AI, and increasing collaborations. Formal navigator certification, education campaigns, and improved health financing are crucial. These efforts aim to improve cancer detection, treatment, and outcomes across Africa's diverse healthcare settings.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"205"},"PeriodicalIF":3.0,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mediating role of resourcefulness in the relationship between perceived stress and benefit finding among non-small cell lung cancer patients: a cross-sectional study. 在非小细胞肺癌患者中,应变能力在感知压力和利益发现之间的中介作用:一项横断面研究。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-14 DOI: 10.1007/s00520-026-10370-1
Yanhua Teng, Ruirui Jia, Ning Ma, Jing Han, Chang Liu

Background: While perceived stress in non-small cell lung cancer (NSCLC) is typically associated with psychological distress, it can also co-occur with positive adaptation, such as benefit finding. It is unclear whether resourcefulness may mediate this association.

Aims: To examine whether resourcefulness mediates the association between perceived stress and benefit finding in patients with NSCLC.

Methods: A cross-sectional study was conducted among NSCLC patients at a single oncology hospital between February and June 2025. Data were collected using a structured questionnaire comprising demographic and clinical characteristics, the Perceived Stress Scale (PSS), the Resourcefulness Scale (RSS), and the Benefit Finding (BF) Scale. Data analysis was performed using SPSS 27.0 and Amos 28.0. Descriptive statistics, independent t-tests, one-way ANOVA, Pearson's correlation, and multiple regression were conducted. To examine the potential mediating pathway of resourcefulness, a structural equation model (SEM) was constructed. The model's goodness-of-fit was assessed using common indices, including χ2/df, GFI, AGFI, NFI, RFI, TLI, CFI, and RMSEA.

Results: A total of 326 NSCLC patients participated. The structural equation model demonstrated a good fit. Path analysis revealed that perceived stress was significantly associated with benefit finding, both directly (β = 0.345, p < 0.001) and indirectly via resourcefulness (β = 0.039, p < 0.001). This provides evidence that resourcefulness partially mediates the relationship between perceived stress and benefit finding in this patient group.

Conclusion: This study found that, among NSCLC patients, higher perceived stress was associated with greater benefit finding, both directly and indirectly through increased resourcefulness. These results suggest that moderate perceived stress may stimulate resourcefulness, which, in turn, helps patients find positive aspects of their experience. Supporting patients' resourcefulness may help them manage stress and achieve better psychological adaptation.

背景:虽然非小细胞肺癌(NSCLC)患者的感知压力通常与心理困扰相关,但它也可能与积极适应(如获益发现)共同发生。目前尚不清楚足智多谋是否可以调解这种联系。目的:研究在非小细胞肺癌患者中,应变能力是否介导了感知压力和获益发现之间的关联。方法:于2025年2月至6月在一家肿瘤医院对非小细胞肺癌患者进行横断面研究。数据采用结构化问卷收集,包括人口统计学和临床特征、感知压力量表(PSS)、机智量表(RSS)和利益发现量表(BF)。采用SPSS 27.0和Amos 28.0进行数据分析。采用描述性统计、独立t检验、单因素方差分析、Pearson相关和多元回归分析。为了探讨智谋的潜在中介途径,构建了结构方程模型。使用常用指标评估模型的拟合优度,包括χ2/df、GFI、AGFI、NFI、RFI、TLI、CFI和RMSEA。结果:共有326例NSCLC患者参与。结构方程模型拟合良好。通径分析显示,感知压力与利益发现之间存在显著的直接相关关系(β = 0.345, p)。结论:本研究发现,在非小细胞肺癌患者中,感知压力越大,利益发现越大,直接或间接地通过增加应变能力来实现。这些结果表明,适度的感知压力可能会刺激足智多谋,这反过来又有助于患者发现他们经历的积极方面。支持患者的智谋可以帮助他们管理压力,实现更好的心理适应。
{"title":"The mediating role of resourcefulness in the relationship between perceived stress and benefit finding among non-small cell lung cancer patients: a cross-sectional study.","authors":"Yanhua Teng, Ruirui Jia, Ning Ma, Jing Han, Chang Liu","doi":"10.1007/s00520-026-10370-1","DOIUrl":"https://doi.org/10.1007/s00520-026-10370-1","url":null,"abstract":"<p><strong>Background: </strong>While perceived stress in non-small cell lung cancer (NSCLC) is typically associated with psychological distress, it can also co-occur with positive adaptation, such as benefit finding. It is unclear whether resourcefulness may mediate this association.</p><p><strong>Aims: </strong>To examine whether resourcefulness mediates the association between perceived stress and benefit finding in patients with NSCLC.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among NSCLC patients at a single oncology hospital between February and June 2025. Data were collected using a structured questionnaire comprising demographic and clinical characteristics, the Perceived Stress Scale (PSS), the Resourcefulness Scale (RSS), and the Benefit Finding (BF) Scale. Data analysis was performed using SPSS 27.0 and Amos 28.0. Descriptive statistics, independent t-tests, one-way ANOVA, Pearson's correlation, and multiple regression were conducted. To examine the potential mediating pathway of resourcefulness, a structural equation model (SEM) was constructed. The model's goodness-of-fit was assessed using common indices, including χ2/df, GFI, AGFI, NFI, RFI, TLI, CFI, and RMSEA.</p><p><strong>Results: </strong>A total of 326 NSCLC patients participated. The structural equation model demonstrated a good fit. Path analysis revealed that perceived stress was significantly associated with benefit finding, both directly (β = 0.345, p < 0.001) and indirectly via resourcefulness (β = 0.039, p < 0.001). This provides evidence that resourcefulness partially mediates the relationship between perceived stress and benefit finding in this patient group.</p><p><strong>Conclusion: </strong>This study found that, among NSCLC patients, higher perceived stress was associated with greater benefit finding, both directly and indirectly through increased resourcefulness. These results suggest that moderate perceived stress may stimulate resourcefulness, which, in turn, helps patients find positive aspects of their experience. Supporting patients' resourcefulness may help them manage stress and achieve better psychological adaptation.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"202"},"PeriodicalIF":3.0,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture combined with nutritional intervention for gastrointestinal cancer-related sarcopenia: a randomized controlled trial using ultrasonographic indices. 电针联合营养干预治疗胃肠道癌相关性肌肉减少症:超声指标随机对照试验。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-14 DOI: 10.1007/s00520-026-10436-0
Luo Zheng, Ji Weilong, Xu Liwei, Zhao Yujie, Zhang Tianyi, Shi Shijie, Lu Xinru, He Weiwei, Zhang Cairong

Objective: This randomized controlled trial aimed to evaluate the efficacy of electroacupuncture combined with nutritional intervention for cancer-related sarcopenia compared to nutritional intervention alone. Muscle thickness and elasticity were assessed using ultrasonography to calculate relevant parameters. By integrating these objective measures with conventional indicators and scales, this study aimed to provide a more comprehensive and intuitive evaluation of changes in muscle function, thereby offering a basis for the clinical application of electroacupuncture combined with nutritional intervention in the treatment of cancer-related sarcopenia.

Methods: Seventy participants were randomly assigned to either a control group receiving nutritional intervention alone or an experimental group receiving electroacupuncture combined with nutritional intervention for 12 weeks. Primary outcome measures included the appendicular skeletal muscle index (ASMI), dominant handgrip strength, 6-m walk time, and multiparameter ultrasound indices. Secondary outcomes included the Mini Nutritional Assessment (MNA), Short Physical Performance Battery (SPPB), body mass index (BMI), and body fat percentage. All measurements were taken at baseline and after the intervention.

Results: The study cohort predominantly consisted of patients diagnosed with gastrointestinal cancers. Following the intervention, participants in the control group demonstrated significant improvements in appendicular skeletal muscle index (ASMI), dominant handgrip strength, body mass index (BMI), ultrasound-derived muscle thickness, and Mini Nutritional Assessment (MNA) scores. However, no statistically significant changes were observed in the 6-m walking speed, body fat percentage, a-Ratio, or short physical performance battery (SPPB) scores. In contrast, the experimental group exhibited statistically significant enhancements across all measured outcomes, including ASMI, handgrip strength, 6-m walking speed, BMI, body fat percentage, muscle thickness by ultrasound, a-Ratio, MNA scores, and SPPB scores. Moreover, the magnitude of improvement in the experimental group surpassed that observed in the control group.

Conclusion: This study demonstrates that electroacupuncture combined with nutritional intervention effectively improves muscle mass, dominant handgrip strength, physical performance, nutritional status, and body composition in patients with gastrointestinal cancer-related sarcopenia, with no significant safety concerns. This approach is worthy of clinical promotion to enhance the quality of life and prognosis of these patients.

目的:本随机对照试验旨在评价电针联合营养干预治疗癌症相关性肌肉减少症的疗效,并与单独营养干预进行比较。超声检查肌肉厚度和弹性,计算相关参数。本研究通过将这些客观指标与常规指标和量表相结合,旨在更全面、直观地评价肌肉功能的变化,从而为电针联合营养干预治疗癌症相关性肌少症的临床应用提供依据。方法:将70名参与者随机分为单独接受营养干预的对照组和接受电针联合营养干预的实验组,为期12周。主要结局指标包括阑尾骨骼肌指数(ASMI)、优势握力、6米步行时间和多参数超声指标。次要结果包括迷你营养评估(MNA)、短体能测试(SPPB)、体重指数(BMI)和体脂率。所有测量均在基线和干预后进行。结果:研究队列主要由诊断为胃肠道癌症的患者组成。干预后,对照组的参与者在阑尾骨骼肌指数(ASMI)、主要握力、体重指数(BMI)、超声来源的肌肉厚度和迷你营养评估(MNA)评分方面表现出显著改善。然而,在6米步行速度、体脂率、a-Ratio或短时间物理性能电池(SPPB)评分方面没有观察到统计学上显著的变化。相比之下,实验组在所有测量结果上都表现出统计学上显著的增强,包括ASMI、握力、6米步行速度、BMI、体脂率、超声测得的肌肉厚度、a-Ratio、MNA评分和SPPB评分。此外,实验组的改善幅度超过了对照组。结论:本研究表明,电针联合营养干预可有效改善胃肠道癌相关性肌肉减少症患者的肌肉量、优势握力、体能、营养状况和身体成分,且无明显的安全性问题。该方法值得临床推广,以提高患者的生活质量和预后。
{"title":"Electroacupuncture combined with nutritional intervention for gastrointestinal cancer-related sarcopenia: a randomized controlled trial using ultrasonographic indices.","authors":"Luo Zheng, Ji Weilong, Xu Liwei, Zhao Yujie, Zhang Tianyi, Shi Shijie, Lu Xinru, He Weiwei, Zhang Cairong","doi":"10.1007/s00520-026-10436-0","DOIUrl":"https://doi.org/10.1007/s00520-026-10436-0","url":null,"abstract":"<p><strong>Objective: </strong>This randomized controlled trial aimed to evaluate the efficacy of electroacupuncture combined with nutritional intervention for cancer-related sarcopenia compared to nutritional intervention alone. Muscle thickness and elasticity were assessed using ultrasonography to calculate relevant parameters. By integrating these objective measures with conventional indicators and scales, this study aimed to provide a more comprehensive and intuitive evaluation of changes in muscle function, thereby offering a basis for the clinical application of electroacupuncture combined with nutritional intervention in the treatment of cancer-related sarcopenia.</p><p><strong>Methods: </strong>Seventy participants were randomly assigned to either a control group receiving nutritional intervention alone or an experimental group receiving electroacupuncture combined with nutritional intervention for 12 weeks. Primary outcome measures included the appendicular skeletal muscle index (ASMI), dominant handgrip strength, 6-m walk time, and multiparameter ultrasound indices. Secondary outcomes included the Mini Nutritional Assessment (MNA), Short Physical Performance Battery (SPPB), body mass index (BMI), and body fat percentage. All measurements were taken at baseline and after the intervention.</p><p><strong>Results: </strong>The study cohort predominantly consisted of patients diagnosed with gastrointestinal cancers. Following the intervention, participants in the control group demonstrated significant improvements in appendicular skeletal muscle index (ASMI), dominant handgrip strength, body mass index (BMI), ultrasound-derived muscle thickness, and Mini Nutritional Assessment (MNA) scores. However, no statistically significant changes were observed in the 6-m walking speed, body fat percentage, a-Ratio, or short physical performance battery (SPPB) scores. In contrast, the experimental group exhibited statistically significant enhancements across all measured outcomes, including ASMI, handgrip strength, 6-m walking speed, BMI, body fat percentage, muscle thickness by ultrasound, a-Ratio, MNA scores, and SPPB scores. Moreover, the magnitude of improvement in the experimental group surpassed that observed in the control group.</p><p><strong>Conclusion: </strong>This study demonstrates that electroacupuncture combined with nutritional intervention effectively improves muscle mass, dominant handgrip strength, physical performance, nutritional status, and body composition in patients with gastrointestinal cancer-related sarcopenia, with no significant safety concerns. This approach is worthy of clinical promotion to enhance the quality of life and prognosis of these patients.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"203"},"PeriodicalIF":3.0,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient symptoms, confidence, and adherence during the first 8 weeks of targeted oral anticancer agent treatment. 在靶向口服抗癌药物治疗的前8周患者的症状、信心和依从性。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-13 DOI: 10.1007/s00520-026-10421-7
Amna Rizvi-Toner, Antoinette B Coe, Christopher R Friese, Milisa Manojlovich, Lauren P Wallner, Karen B Farris

Purpose: We aimed to understand patients' initial experiences with targeted oral anticancer agents (OAAs). We investigated symptoms experienced and how symptom severity affected patient confidence to manage and seek care for symptoms and OAA adherence.

Methods: We conducted a longitudinal prospective cohort study of patients during the first 8 weeks of targeted OAA treatment at an NCI-designated cancer center. Participants completed patient-reported outcome measures (PROMs) online at three timepoints. Descriptive statistics quantified demographics, cancer characteristics, symptom severity, confidence, and OAA adherence. Logistic regression was used to estimate confidence and adherence by each symptom at each timepoint. Mixed effects logistic regressions accounted for repeated measures and time effects on outcomes.

Results: Participants (n = 59) reported severe symptoms at all timepoints. Tiredness and drowsiness were most frequently reported as severe. Participants' confidence increased from timepoint 1 to 3. Most participants reported high confidence (61-86%) and excellent adherence (75-80%) across all timepoints, but 20-25% had less than excellent OAA adherence. High confidence to manage symptoms was positively associated with older age. Confidence to manage symptoms was inversely related to the severity of depression, tiredness, drowsiness, constipation, and tingling/numbness.

Conclusion: Confidence to manage symptoms increased with time on OAAs, but severe symptoms persisted. Although self-reported OAA adherence was high, a notable number of participants reported suboptimal adherence. Relationships between confidence, symptom severity, and adherence should be identified in clinical settings to evaluate patients who may need extra clinical support during OAA treatment.

目的:我们旨在了解患者使用靶向口服抗癌药物(OAAs)的初始体验。我们调查了所经历的症状,以及症状严重程度如何影响患者管理和寻求症状护理的信心和OAA依从性。方法:我们在nci指定的癌症中心进行了一项纵向前瞻性队列研究,研究对象是接受靶向OAA治疗的前8周患者。参与者在三个时间点在线完成患者报告的结果测量(PROMs)。描述性统计量化了人口统计学、癌症特征、症状严重程度、信心和OAA依从性。采用Logistic回归估计每个症状在每个时间点的置信度和依从性。混合效应逻辑回归解释了重复测量和时间对结果的影响。结果:参与者(n = 59)在所有时间点报告了严重症状。疲劳和困倦是最常见的严重症状。参与者的信心从时间点1增加到时间点3。大多数参与者在所有时间点都报告了高信心(61-86%)和良好的依从性(75-80%),但20-25%的参与者没有达到良好的OAA依从性。对控制症状的高度自信与年龄的增长呈正相关。控制症状的信心与抑郁、疲劳、嗜睡、便秘和麻刺感/麻木的严重程度成反比。结论:随着OAAs治疗时间的延长,治疗症状的信心增加,但严重症状持续存在。尽管自我报告的OAA依从性很高,但显著数量的参与者报告的依从性不是最佳的。在临床环境中,应确定信心、症状严重程度和依从性之间的关系,以评估在OAA治疗期间可能需要额外临床支持的患者。
{"title":"Patient symptoms, confidence, and adherence during the first 8 weeks of targeted oral anticancer agent treatment.","authors":"Amna Rizvi-Toner, Antoinette B Coe, Christopher R Friese, Milisa Manojlovich, Lauren P Wallner, Karen B Farris","doi":"10.1007/s00520-026-10421-7","DOIUrl":"10.1007/s00520-026-10421-7","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to understand patients' initial experiences with targeted oral anticancer agents (OAAs). We investigated symptoms experienced and how symptom severity affected patient confidence to manage and seek care for symptoms and OAA adherence.</p><p><strong>Methods: </strong>We conducted a longitudinal prospective cohort study of patients during the first 8 weeks of targeted OAA treatment at an NCI-designated cancer center. Participants completed patient-reported outcome measures (PROMs) online at three timepoints. Descriptive statistics quantified demographics, cancer characteristics, symptom severity, confidence, and OAA adherence. Logistic regression was used to estimate confidence and adherence by each symptom at each timepoint. Mixed effects logistic regressions accounted for repeated measures and time effects on outcomes.</p><p><strong>Results: </strong>Participants (n = 59) reported severe symptoms at all timepoints. Tiredness and drowsiness were most frequently reported as severe. Participants' confidence increased from timepoint 1 to 3. Most participants reported high confidence (61-86%) and excellent adherence (75-80%) across all timepoints, but 20-25% had less than excellent OAA adherence. High confidence to manage symptoms was positively associated with older age. Confidence to manage symptoms was inversely related to the severity of depression, tiredness, drowsiness, constipation, and tingling/numbness.</p><p><strong>Conclusion: </strong>Confidence to manage symptoms increased with time on OAAs, but severe symptoms persisted. Although self-reported OAA adherence was high, a notable number of participants reported suboptimal adherence. Relationships between confidence, symptom severity, and adherence should be identified in clinical settings to evaluate patients who may need extra clinical support during OAA treatment.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"196"},"PeriodicalIF":3.0,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146182379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key issues in palliative and supportive care research, policy and practice. 缓和和支持性护理研究、政策和实践中的关键问题。
IF 3 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-13 DOI: 10.1007/s00520-026-10422-6
E G Boland, J W Boland, J Koffman
{"title":"Key issues in palliative and supportive care research, policy and practice.","authors":"E G Boland, J W Boland, J Koffman","doi":"10.1007/s00520-026-10422-6","DOIUrl":"https://doi.org/10.1007/s00520-026-10422-6","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"34 3","pages":"194"},"PeriodicalIF":3.0,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146182363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Supportive Care in Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1